Share on facebook
Share on twitter
Share on linkedin

June 20, 2016: Two GMP Drug Product Manufacturing Runs Completed: Lyophilized Clinical Supplies Prepared

BioAegis Therapeutics announced that it has completed two successful manufacturing runs to produce lyophilized clinical supplies of plasma gelsolin. The drug product in this formulation has already been found to be highly temperature-stable in over two years of stability studies, which are ongoing. The lypophilization of biologics is utilized to eliminate the necessity of cold-chain storage, facilitating use in the clinic and minimizing storage and shipping costs.